PreventT2 Together: Examining the Efficacy of Couple-based Lifestyle Intervention to Prevent Type 2 Diabetes
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Utah
About this trial
Nearly half of adults in the United States have or are at risk of developing type 2 diabetes. The overall goal of this community-engaged research is to examine the efficacy of an innovative couple-based lifestyle intervention to prevent type 2 diabetes that is applicable to a broad range of partnered adults in the United States. By simultaneously targeting lifestyle and perceived support from romantic partners, there is a high likelihood of creating lasting changes in both
Eligibility criteria
Qualifiers
BMI ≥ 25 kg/m² (≥ 23 kg/m² if Asian American), and
Do not have a diagnosis of type 1 or type 2 diabetes, and
Not currently pregnant, and
High risk for type 2 diabetes based on: (i) CDC Prediabetes Risk Test score ≥ 5, (ii) clinically diagnosed Gestational Diabetes during a previous pregnancy (for women), or (iii) a blood test result indicative of prediabetes in the past year (i.e., fasting blood glucose 100-125 mg/dl; plasma glucose 140-199 mg/dl measured 2 hours after a 75 g glucose load; or HbA1c 5.7%-6.4%).
Disqualifiers
"Supporting partner" has a diagnosis of Type 2 Diabetes.
Has a diagnosis of another chronic disease (unless no major events/changes for 3+ months), or
Is currently on medication or engaged in lifestyle intervention for prediabetes or obesity, or
Has previously participated in the National DPP, or
Trial design
Treatments tested in this trial
- Individual intervention condition (PreventT2)
- Couple-based intervention condition (PreventT2 Together; couple-based adaptation of 2021 PreventT2; approved by the CDC in November 2022 as an Alternate Curriculum for use in the NDPP)
Treatment groups
324 Participants
are divided into 2 treatment groupsSponsors and collaborators
University of Utah
Lead sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator
Source ClinicalTrials.gov